HIF1A and cancer: This study aimed to focus on the cause of therapy resistance from the perspective of tumor cell adaptation to a hypoxic microenvironment, particularly discussing the capacity of oxygen-regulated transcription factor HIF-1 in modifying cancer sensitivity to therapeutic agents.